Showing results (111-120 of 235) with videos related to
Sort By:
Pageof 24
The Lancet. Healthy Longevity|July 5, 2025
Influence of age on the association of vascular risk factors with acute stroke (INTERSTROKE): a case-control studyCatriona Reddin, Graeme J Hankey, John Ferguson, et al.European Heart Journal|August 28, 2023
Frailty and outcomes in heart failure patients from high-, middle-, and low-income countriesDarryl P Leong, Philip Joseph, John J V McMurray, et al.Journal of Human Hypertension|June 5, 2021
Position statement on use of pharmacological combinations in a single pill for treatment of hypertension by Argentine Federation of Cardiology (FAC) and Argentine Society of Hypertension (SAHA)Nicolás Renna, Daniel Piskorz, Diego Stisman, et al.Circulation|June 25, 2015
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialAlvaro Avezum, Renato D Lopes, Phillip J Schulte, et al.Neurology|October 11, 2022
Alcohol Intake as a Risk Factor for Acute Stroke: The INTERSTROKE StudyAndrew Smyth, Martin O'Donnell, Sumathy Rangarajan, et al.Journal of Stroke|September 26, 2024
Carbonated Beverage, Fruit Drink, and Water Consumption and Risk of Acute Stroke: the INTERSTROKE Case-Control StudyAndrew Smyth, Graeme J Hankey, Albertino Damasceno, et al.American Heart Journal|May 16, 2016
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialRaffaele De Caterina, Ulrika Andersson, John H Alexander, et al.Journal of the American College of Cardiology|February 5, 2025
Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE): A Prospective Cohort StudyPhilip Joseph, Álvaro Avezum, Chinthanie Ramasundarahettige, et al.Diabetes, Obesity & Metabolism|January 5, 2022
Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trialPeter J Raubenheimer, William C Cushman, Alvaro Avezum, et al.Journal of Hypertension|April 10, 2019
Prevalence, awareness, treatment and control of hypertension in rural and urban communities in Latin American countriesPablo Lamelas, Rafael Diaz, Andres Orlandini, et al.Pageof 24